HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Xie Selected Research

guanjiekang

12/2016Simultaneous Determination of Multiple Components in Guanjiekang in Rat Plasma via the UPLC-MS/MS Method and Its Application in Pharmacokinetic Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Xie Research Topics

Disease

110Neoplasms (Cancer)
10/2022 - 12/2009
26Breast Neoplasms (Breast Cancer)
10/2022 - 11/2014
19Inflammation (Inflammations)
01/2022 - 05/2008
17Neoplasm Metastasis (Metastasis)
05/2022 - 12/2009
12Rheumatoid Arthritis
08/2022 - 11/2005
12Lung Neoplasms (Lung Cancer)
02/2022 - 02/2010
11Nasopharyngeal Carcinoma
01/2018 - 12/2005
10Fibrosis (Cirrhosis)
11/2022 - 08/2014
10Carcinogenesis
01/2022 - 04/2014
9Hypoxia (Hypoxemia)
01/2022 - 01/2017
9Colitis
01/2022 - 09/2010
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2010
9Liver Diseases (Liver Disease)
01/2020 - 05/2013
8Multiple Myeloma
01/2022 - 01/2018
8Necrosis
12/2021 - 11/2003
8Hepatocellular Carcinoma (Hepatoma)
08/2021 - 10/2014
7Atherosclerosis
09/2022 - 04/2008
7Arthritis (Polyarthritis)
08/2022 - 11/2005
6Triple Negative Breast Neoplasms
01/2022 - 01/2017
6Crohn Disease (Crohn's Disease)
01/2022 - 09/2010
6Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 01/2016
6Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 01/2018
5Type 2 Diabetes Mellitus (MODY)
11/2022 - 08/2009
5Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 11/2014
5COVID-19
05/2021 - 01/2020
5Pain (Aches)
02/2021 - 09/2016
4Disease Progression
11/2022 - 11/2019
4Wounds and Injuries (Trauma)
03/2022 - 01/2014
4Heart Failure
03/2022 - 04/2018
4Ulcerative Colitis
01/2022 - 08/2019
4Hemorrhage
01/2022 - 01/2009
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 01/2019
4Body Weight (Weight, Body)
05/2021 - 10/2016
4Chronic Disease (Chronic Diseases)
04/2021 - 01/2020
4Gouty Arthritis
02/2021 - 09/2016
3Vomiting
01/2022 - 02/2020
3Edema (Dropsy)
01/2022 - 10/2017
3Malnutrition (Nutritional Deficiencies)
01/2022 - 03/2011
3Carcinoma (Carcinomatosis)
01/2022 - 01/2019
3Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2020
3Liver Neoplasms (Liver Cancer)
10/2021 - 01/2014
3Non-alcoholic Fatty Liver Disease
10/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
10/2022 - 08/2014
21Pharmaceutical PreparationsIBA
09/2022 - 11/2005
18Biomarkers (Surrogate Marker)IBA
02/2022 - 11/2003
17MicroRNAs (MicroRNA)IBA
01/2021 - 02/2010
10Small Interfering RNA (siRNA)IBA
12/2021 - 09/2014
9EnzymesIBA
12/2021 - 11/2014
8Messenger RNA (mRNA)IBA
01/2022 - 05/2011
8LipidsIBA
12/2021 - 04/2008
8Biological ProductsIBA
08/2021 - 12/2005
7Transcription Factors (Transcription Factor)IBA
07/2022 - 11/2014
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2016
7Silybin (Lagosa)IBA
01/2021 - 01/2017
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2017
6LigandsIBA
01/2022 - 01/2012
6CytokinesIBA
01/2022 - 01/2018
6Chemokine ReceptorsIBA
12/2021 - 01/2016
6Therapeutic UsesIBA
12/2021 - 06/2011
6DNA (Deoxyribonucleic Acid)IBA
10/2021 - 06/2006
6Peptides (Polypeptides)IBA
11/2020 - 02/2014
5CollagenIBA
11/2022 - 10/2017
5Cisplatin (Platino)FDA LinkGeneric
02/2022 - 01/2018
5AlkaloidsIBA
01/2022 - 05/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2017
5AcidsIBA
01/2022 - 01/2015
5AntioxidantsIBA
06/2021 - 01/2018
5Liposomes (Liposome)IBA
01/2021 - 01/2015
5RNA (Ribonucleic Acid)IBA
01/2021 - 01/2019
5Phenobarbital (Luminal)FDA Link
10/2019 - 11/2014
5Chloroquine (Aralen)FDA LinkGeneric
01/2018 - 03/2016
4Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2018
4nobiletinIBA
08/2022 - 12/2015
4CholesterolIBA
12/2021 - 01/2017
4ChemokinesIBA
01/2021 - 01/2014
4ProdrugsIBA
01/2021 - 01/2017
4Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 04/2019
4AntigensIBA
10/2020 - 09/2008
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2020 - 07/2017
4Dextrans (Dextran)FDA Link
01/2020 - 07/2017
4oxidized low density lipoproteinIBA
11/2019 - 01/2015
4SilymarinIBA
10/2019 - 05/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 12/2009
46-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2018 - 01/2015
4Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2017 - 06/2014
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
08/2022 - 02/2020
3Long Noncoding RNAIBA
03/2022 - 08/2019
3Formaldehyde (Formol)FDA Link
01/2022 - 11/2003
3Proteasome InhibitorsIBA
01/2022 - 01/2020
3Dinoprostone (PGE2)FDA Link
01/2022 - 01/2018
3ElafinIBA
01/2022 - 01/2020
3Histone MethyltransferasesIBA
01/2022 - 01/2021
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 11/2019

Therapy/Procedure

44Therapeutics
11/2022 - 12/2010
17Drug Therapy (Chemotherapy)
06/2022 - 12/2015
15Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2022 - 05/2015
6Immunotherapy
01/2022 - 03/2010
4Percutaneous Coronary Intervention
09/2022 - 01/2009
4Photochemotherapy (Photodynamic Therapy)
11/2019 - 12/2009
4Radiotherapy
05/2019 - 06/2012